Axa Taps New Client Chief for Asia-Pacific and Europe as Buyback Counters Shareplan Dilution

Axa appoints Dr. Thomas Götting as Chief Client & Distribution Officer for Asia-Pacific and Europe at AXA XL, effective October 1.

Axa has placed a seasoned executive at the helm of client relationships across two of its most important regions, naming Dr. Thomas Götting as Chief Client & Distribution Officer for Asia-Pacific and Europe within its commercial lines arm, AXA XL. The appointment takes effect on October 1 and fills a role that sits directly between the insurer's largest corporate customers and its distribution partners.

The move lands as the French group works through a broader operational reshuffle and a capital-return program designed to keep its shareholder base intact.

Buyback Set to Offset Employee Plan

To neutralize the dilution that would otherwise stem from its Shareplan 2026 employee participation program, Axa agreed to repurchase and subsequently cancel its own shares. The company has earmarked up to EUR 470.8 million for the effort, with completion targeted no later than October 29, 2026.

The stock ended Friday at EUR 41.96, capping a seven-day stretch in which it shed 5.5 percent. That leaves the shares 8.6 percent below their 52-week high as autumn begins, while the 50-day moving average of EUR 44.15 sits well above the current price — a gap that keeps pressure on the insurer to show a near-term operational turnaround.

Analysts Trim Targets, Keep Bullish Ratings

Research desks spent late September recalibrating their models. On September 25, RBC Capital analyst Ben Cohen cut his price target to EUR 52 from EUR 54 while leaving his "Outperform" rating untouched, signaling continued faith in the stock's recovery potential despite the modest reduction. Four days earlier, Goldman Sachs had raised its own target to EUR 50 and maintained a "Buy" recommendation. Other market watchers place fair value in the same neighborhood.

Those revisions followed the mid-September unveiling of the "Growing Forward" medium-term plan, which sets the financial framework for 2027 through 2029 and maps out the group's future growth areas. Since that presentation roughly two weeks ago, the stock has lost 3.2 percent.

ICC Contract Ends Amid Sanctions Concerns

Alongside the personnel change in commercial lines, Axa reached a mutual agreement with the International Criminal Court to terminate an existing health insurance contract. Reuters had earlier reported concerns about potential US sanctions exposure, and the court has since shifted to an unnamed provider. Reports from Reuters and the Financial Times tie the decision to the tribunal's efforts to shield itself from possible American sanctions.

The episode illustrates how far geopolitical friction can reach into the traditional insurance business. For Axa, it means the loss of a high-profile institutional client — but it also underscores how carefully international organizations are recalibrating their risk management against external sanctions threats.

Third-Quarter Indicators on the Horizon

Investors now turn their attention to the group's operating performance. On October 29, 2026, Axa will publish activity indicators for the first nine months of the current financial year. Those figures should shed light on how resilient the property-casualty and life insurance businesses have been against recent market shifts — and whether the gap between the share price and its moving average begins to close.